Description: SomnoMed Limited is engaged in the business of producing and selling devices for the oral treatment of sleep related disorders primarily in the Asia Pacific region, North America and Europe. The Company's products include SomnoDent Fusion, SomnoDent Flex, SomnoDent Classic, Somnodent SUAD, Somnodent SUAD Ultra, SomnoDent Herbst Advance, SomnoDent AIR & AIR+ and Morning Repositioner. The SomnoDent Herbst Advance is an intraoral device featuring a visual calibration indicator for the treatment of obstructive sleep apnea (OSA). The Company manufactures custom fit acrylic occlusal splints (dental guards), the SomnoBrux, to protect patient's teeth against heaving grinding and bruxism. Its SomnoBrux products include Gelb, Tanner and Michigan. It offers SOMGauge, which is an autoclavable instrument that can be used to construct reliable bite records. The Company provides medical reimbursement services to assist dental offices with submitting a medical claim for their patients' OSA treatment.
Home Page: somnomed.com/au/
SOM Technical Analysis
20 Clarke Street
Crows Nest,
NSW
2065
Australia
Phone:
61 2 9467 0400
Officers
| Name | Title |
|---|---|
| Mr. Neil Verdal-Austin B.Com., C.A. | Global CEO, MD & Director |
| Mr. Hervé Fiévet | Global Chief Financial Officer |
| Mr. Mark Harding | VP of Global Marketing |
| Mr. Matthew Conlon | Exec. VP Sales & Marketing - North America |
| Mr. Marco Van Kleef | VP of Marketing & Sales - Europe |
| Dr. Jagdeep Bijwadia | Chief Medical Officer |
| Mr. Terence A. Flitcroft B.Com., B.Comm., C.A., CA, SF FIN | Company Sec. |
| Dr. Peter Spencer MBA Ph.D., MAICD | Gen. Mang. of Operations |
| Mr. Christopher Bedford | VP of Global Production and Product Devel. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.4915 |
| Price-to-Sales TTM: | 1.3368 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |